Abstract
BackgroundIn April 2016, following a preliminary analysis1 and the production process validation, the Central IntraVenous Additive Services (CIVAS) completed and introduced a robotic system for the compounding of non-toxic intravenous...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
